- Home
- MRNA vs GPN Comparison
MRNA vs GPN Comparison
Compare MRNA & GPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- GPN
- Stock Information
- Founded
- MRNA 2010
- GPN 1967
- Country
- MRNA United States
- GPN United States
- Employees
- MRNA N/A
- GPN N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- GPN Business Services
- Sector
- MRNA Health Care
- GPN Consumer Discretionary
- Exchange
- MRNA Nasdaq
- GPN Nasdaq
- Market Cap
- MRNA 34.6B
- GPN 28.1B
- IPO Year
- MRNA 2018
- GPN 2001
- Fundamental
- Price
- MRNA $54.82
- GPN $101.60
- Analyst Decision
- MRNA Hold
- GPN Buy
- Analyst Count
- MRNA 16
- GPN 26
- Target Price
- MRNA $95.93
- GPN $140.65
- AVG Volume (30 Days)
- MRNA 5.0M
- GPN 2.9M
- Earning Date
- MRNA 11-07-2024
- GPN 10-29-2024
- Dividend Yield
- MRNA N/A
- GPN 0.98%
- EPS Growth
- MRNA N/A
- GPN 81.60
- EPS
- MRNA N/A
- GPN 5.46
- Revenue
- MRNA $5,050,000,000.00
- GPN $9,898,458,000.00
- Revenue This Year
- MRNA N/A
- GPN N/A
- Revenue Next Year
- MRNA $5.29
- GPN $6.93
- P/E Ratio
- MRNA N/A
- GPN $18.63
- Revenue Growth
- MRNA N/A
- GPN 6.63
- 52 Week Low
- MRNA $54.82
- GPN $91.60
- 52 Week High
- MRNA $170.47
- GPN $141.78
- Technical
- Relative Strength Index (RSI)
- MRNA 25.28
- GPN 47.24
- Support Level
- MRNA $55.70
- GPN $98.10
- Resistance Level
- MRNA $59.73
- GPN $103.99
- Average True Range (ATR)
- MRNA 2.17
- GPN 2.22
- MACD
- MRNA 0.29
- GPN 0.43
- Stochastic Oscillator
- MRNA 0.00
- GPN 69.04
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About GPN Global Payments Inc.
Global Payments is a leading provider of payment processing and software solutions and focuses on serving small and midsize merchants. The company operates in 30 countries and generates about one fourth of its revenue from outside North America, primarily in Europe and Asia. In 2019, Global Payments merged with Total System Services in an all-stock deal that gave Total System Services shareholders 48% of the combined company's shares. The merger added issuer processing operations.